Zobrazeno 1 - 2
of 2
pro vyhledávání: ''
Autor:
A Azad, K. Hui, Ellen Warner, S Ahmed, S Sridhar, D C Hodgson, K Morarji, O McArdle, Ellen M. Greenblatt, A M F Ali, G Gingras-Hill
Publikováno v:
Current Oncology
Volume 24
Issue 6
Pages 3335-502
Volume 24
Issue 6
Pages 3335-502
As cure rates for breast cancer improve, there is increasing evidence that late effects of treatment&mdash
and impaired fertility in particular&mdash
are emerging as important concerns among young breast cancer survivors. Older reports have
and impaired fertility in particular&mdash
are emerging as important concerns among young breast cancer survivors. Older reports have
Publikováno v:
Current Oncology
The third-generation aromatase inhibitors (AIs) are largely replacing tamoxifen in the adjuvant treatment of early-stage breast cancer in postmenopausal women with hormone receptor–positive tumours. To date, multiple trials have been conducted comp